Literature DB >> 17934782

Application of methods for viral clearance in stem cell production.

Fernando Cobo1.   

Abstract

Regenerative medicine therapies will allow in the future the transplant of cells of human origin in some diseases that until now have been incurable. The assurance of the safety and quality, especially from a microbiological point of view, is very important for these therapeutic products. Depending on the starting material, there are several sources of pathogen presence, mainly human viruses. Also, the use of feeders of animal origin as layers in which the stem cells can grow may permit the transmission of animal pathogens to these cells. However, cell sources are limited due to the low availability of spare in vitro fecundation human embryos and the low rate of success in the derivation of human stem cell lines. Thus, in several cases, it will be necessary to evaluate the possibility of removing or inactivating these microorganisms. In this paper, we summarize the main methods of viral clearance and we have provided an overview of the main features taking into account in the viral clearance techniques.

Entities:  

Mesh:

Year:  2007        PMID: 17934782     DOI: 10.1007/s11626-007-9059-8

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  32 in total

Review 1.  Stem cells in the umbilical cord.

Authors:  Mark L Weiss; Deryl L Troyer
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 2.  Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination.

Authors:  Francesca Bonvicini; Giorgio Gallinella; Giovanna Angela Gentilomi; Simone Ambretti; Monica Musiani; Marialuisa Zerbini
Journal:  Clin Lab       Date:  2006       Impact factor: 1.138

3.  Quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. ICH Harmonised Tripartite Guideline.

Authors: 
Journal:  Dev Biol Stand       Date:  1998

4.  Inactivation and elimination of viruses during preparation of human intravenous immunoglobulin.

Authors:  Y Uemura; Y H Yang; C M Heldebrant; K Takechi; K Yokoyama
Journal:  Vox Sang       Date:  1994       Impact factor: 2.144

5.  Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope.

Authors:  Yossef Raviv; Mathias Viard; Julian W Bess; Elena Chertova; Robert Blumenthal
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins.

Authors:  Kurt Brorson; Sherrie Krejci; Kitty Lee; Elizabeth Hamilton; Kathryn Stein; Yuan Xu
Journal:  Biotechnol Bioeng       Date:  2003-05-05       Impact factor: 4.530

7.  Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use.

Authors:  H M Lazarus; S E Haynesworth; S L Gerson; N S Rosenthal; A I Caplan
Journal:  Bone Marrow Transplant       Date:  1995-10       Impact factor: 5.483

Review 8.  Assessment of the viral safety of antivenoms fractionated from equine plasma.

Authors:  Thierry Burnouf; Elwyn Griffiths; Ana Padilla; Salwa Seddik; Marco Antonio Stephano; José-María Gutiérrez
Journal:  Biologicals       Date:  2004-09       Impact factor: 1.856

Review 9.  Diagnostic approaches for viruses and prions in stem cell banks.

Authors:  Fernando Cobo; Paloma Talavera; Angel Concha
Journal:  Virology       Date:  2005-12-27       Impact factor: 3.616

Review 10.  Microbiological control in stem cell banks: approaches to standardisation.

Authors:  Fernando Cobo; Glyn N Stacey; Charles Hunt; Carmen Cabrera; Ana Nieto; Rosa Montes; José Luis Cortés; Purificación Catalina; Angela Barnie; Angel Concha
Journal:  Appl Microbiol Biotechnol       Date:  2005-10-26       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.